A successful live birth with in vitro fertilization and thawed embryo transfer after conservative treatment of recurrent endometrial cancer. (2nd January 2018)

• Record Type: Journal Article
• Authors: Kim, Sung Woo; Kim, Hoon; Ku, Seung-Yup; Suh, Chang Suk; Kim, Seok Hyun; Choi, Young Min
• Is Part Of: Gynecological endocrinology. Volume 34:Number 1(2018)
• Page Start: 15
• Page End: 19
• Publication Date: 2018-01-02
• Subjects: Progestin -- assisted reproductive technology -- thawed embryo transfer -- letrozole -- recurrent endometrial cancer; Endocrine gynecology -- Periodicals; Generative organs, Female -- Diseases -- Periodicals; 618.1
• DOI: 10.1080/09513590.2017.1342239
• Languages: English
• ISSNs: 0951-3590

Abstract

Abstract: Estrogen-dependent early stage endometrial cancer is relatively common in young women of reproductive age. The standard treatment is hysterectomy and bilateral salpingo-oophorectomy (BSO), even in early stage well-differentiated endometrial cancer patients. This surgical option results in permanent loss of fertility. There have been some reports of live births using in vitro fertilization after conservative management of endometrial cancer with high-dose progestin for the purpose of fertility preservation. However, most were not recurrent cases and pregnancy was achieved through conventional in vitro fertilization, which usually raises serum estradiol levels and may lead to the recurrence of endometrial cancer. To date, it is hard to find a case that can be referred for any possible different approach needed for the patients who experience recurrence. Here we report a successful live birth with in vitro fertilization using letrozole to maintain physiological levels of estradiol, and subsequent thawed embryo transfer after elective cryopreservation of embryos in a patient with recurrent endometrial cancer. There has been no evidence of disease recurrence at one year after delivery.